Navigation Links
Use of psychedelic drugs remains prevalent in the United States
Date:4/23/2013

In their article "Over 30 million psychedelic users in the United States", Teri S Krebs and Pl-rjan Johansen from the Department of Neuroscience at Norwegian University of Science and Technology, use data from a randomly-selected sample of over 57,000 individuals surveyed for the 2010 National Survey on Drug Use and Health (NSDUH), to estimate lifetime prevalence of psychedelic use. The authors estimate that approximately 32 million people have used LSD (lysergic acid diethylamide), psilocybin ("magic mushrooms"), or mescaline (peyote and other cacti) in their lifetime. This includes 17% of US adults aged 21 to 64 years. The highest rate of psychedelic use was in the 30 to 34 age group, with an overall rate of 20%, or 26% of males and 15% of females.

"Lifetime use of psychedelics doesn't seem to have changed much since the sixties - psychedelics continue to be widely used in the US and worldwide," the researchers say.

The mechanisms of action, subjective effects, and risk profile of the classical serotonergic psychedelics, distinguish them from other drugs, the authors wrote.

"Psychedelics are different from other drugs, in that they are not known to be physically harmful or cause addiction or compulsive use. Experts agree that psychedelics are less harmful than alcohol and most other recreational drugs, although psychedelics can elicit anxiety and confusion during the drug effects", the researchers say.

The authors estimated that older adults were more likely to have used LSD and mescaline, whereas younger adults were more likely to have used "magic mushrooms". In addition, the authors note that use of "magic mushrooms" is known to have increased since the 1970s.

"People often report mystical experiences as a major reason for using psychedelics. Archaeological evidence shows that psychedelic plants have been used in the Americas for over 5000 years, and currently around 300,000 people in the US enjoy a recognized religious freedom right to use psychedelics." Krebs and Johansen said.


'/>"/>

Contact: Eleanor Howell
press@f1000.com
44-020-763-19129
Faculty of 1000: Biology and Medicine
Source:Eurekalert

Related medicine news :

1. Pancreatic Cancer Correlation to Type 2 Diabetes Drugs Januvia and Byetta, New Studies Find Possible Connection
2. HIV Drugs May Help Protect Young Patients Hearts: Study
3. Is your migraine preventive treatment balanced between drugs benefits and harms?
4. Drugs Can Cut Breast Cancer Risk for Some, Task Force Finds
5. Lucintel Report Outlines $100 Billion Market for Global Oncology Drugs Industry in 2018
6. No evidence drugs, vitamins, supplements help prevent cognitive decline in healthy older adults
7. Interactions between drugs can also be measured at lowest doses
8. GUMBOS technology promises new drugs, electronic devices
9. TGen-Scottsdale Healthcare clinical trial finds new class of cancer drugs safe and effective
10. FDA and Legislators Introduce Bill Aimed at Reclassifying and Restricting Hydrocodone Drugs
11. Cisplatin-resistant cancer cells sensitive to experimental anticancer drugs, PARP inhibitors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
Breaking Medicine Technology: